Silent surge: western excess deaths ignite outcry over medical ethics and data cover-ups

By mid-2026, excess mortality has surged globally, with countries like the UK, Australia, the US, Canada, Ireland, and the Netherlands reporting deaths significantly above expected baselines despite low COVID-19 mortality. For instance, the UK has seen weekly excess deaths climb from 315 in 2020 to over 1,500 by late 2022, while Australia experienced a 17.1% increase in deaths during the first half of 2022, and the US has consistently maintained excess deaths above 10% since 2020. This widespread pattern underscores a global phenomenon of rising mortality beyond the direct impact of the virus itself, signaling a complex public health challenge.

The majority of these excess deaths are attributed to non-COVID causes, with cardiovascular disease and diabetes emerging as prominent contributors, as noted by epidemiologist Veena Raleigh of The King’s Fund. This shift highlights the indirect health consequences of the pandemic, including delayed medical care and the long-term effects of lockdowns. Moreover, excess mortality spans all age groups, including younger populations aged 0 to 24, though older adults (85+) bear the highest absolute burden, reflecting a broad demographic impact that challenges assumptions about pandemic mortality dynamics.

Despite the alarming rise in non-COVID excess deaths, there is a striking lack of mainstream media coverage and governmental acknowledgment, particularly in the UK where outlets like the BBC have largely ignored the issue. Public health experts such as Amitava Banerjee emphasize that indirect effects of the pandemic may cause more deaths and morbidity than COVID itself, yet official investigations into potential drivers—including the role of medications like midazolam and morphine in care home deaths—remain absent. This silence persists even as excess mortality reaches levels comparable to major national tragedies, underscoring an urgent need for transparent discourse and policy response.

Regional contrasts further complicate the picture: while Western countries grapple with sustained high excess mortality, Eastern European nations like Bulgaria exhibit lower-than-expected death rates post-pandemic, consistent with mortality displacement where vulnerable populations succumbed earlier. In Europe, the EU recorded a 16% surge in excess deaths by July 2022, with countries such as Spain, Cyprus, and Greece experiencing spikes exceeding 30%. Contributing factors likely include post-COVID complications, delayed healthcare access, psychological stress from lockdowns, and environmental stressors like heat waves, painting a multifaceted landscape of mortality trends beyond the pandemic’s acute phase.

Cardiovascular disease stands out as a primary proximate cause of the rising global excess mortality post-pandemic, with deaths from ischemic heart disease, heart failure, and arrhythmias significantly elevated. Experts like Amitava Banerjee emphasize that indirect effects—such as delayed treatment and healthcare disruptions—are likely causing more deaths and morbidity than COVID-19 itself, underscoring systemic healthcare failures rather than viral infection as the main driver.

Non-COVID excess deaths have surged dramatically since 2020, with weekly figures rising from 315 to over 1,500 recently, totaling more than 24,000 deaths since mid-2022. This alarming trend is evident across Western countries like the US, UK, and Australia, where excess mortality remains 10-20% above expected levels despite declining COVID cases, suggesting that delayed healthcare access, disrupted chronic disease management, and uninvestigated factors—such as medication use in care homes—are fueling a silent public health emergency largely ignored by authorities.

Beyond immediate causes, distal factors such as post-COVID syndromes involving thromboembolic complications, lockdown-induced psychological and physical sequelae, and environmental stressors like heat waves are contributing to excess mortality. Funeral directors and embalmers report unprecedented clotting patterns, while physicians call for transparent data on vaccination status and independent reviews to unravel these complex, multifactorial drivers that extend well beyond direct viral effects.

The excess mortality burden spans all age groups, including younger populations (0-24 years), but disproportionately affects older adults, with conditions like cerebrovascular disease, cancers, respiratory illnesses, diabetes, and Parkinson’s disease implicated. However, the underlying causes leading to these proximate conditions remain unclear, highlighting a critical need for deeper investigation into systemic healthcare gaps, delayed diagnoses, and long-term treatment inadequacies that have emerged in the pandemic’s wake.

The clinical management of patients during the pandemic has come under intense scrutiny, particularly regarding the use of midazolam and morphine in end-of-life care. The Scottish COVID-19 Inquiry revealed troubling accounts of these sedatives being administered prematurely to patients who were still mobile or exhibiting mild symptoms, raising ethical concerns about hastened deaths under protocols like NICE's NG163. Families reported distress over unexplained do-not-resuscitate orders and lack of informed consent, highlighting significant procedural controversies and the urgent need for comprehensive, transparent investigations into the timing and impact of these drug administrations across regions.

Statistical analyses have uncovered a striking correlation between spikes in UK excess mortality and the widespread use of midazolam during COVID-19 peaks, with a 98.8% increase in excess deaths in April 2020 coinciding with its administration. This correlation, with coefficients exceeding 90%, suggests that many deaths attributed to COVID-19 may have been iatrogenic, challenging the plausibility of the early 2020 infection fatality rate of 24.3%. Despite these alarming patterns, the UK coroner system largely failed to investigate or flag the potential role of these medical interventions, representing a critical oversight in both medical and legal governance.

Beyond midazolam, reports from medical professionals and funeral industry workers have noted unusual pathological findings such as extensive blood clots in deceased individuals post-pandemic, including 'white type clots' linked to thrombotic pulmonary embolism in younger patients. These observations, coupled with cases where hospitals refused autopsies on sudden deaths of vaccinated individuals—prompting legal challenges—fuel suspicions of concealed iatrogenic causes. Calls from physicians for independent review bodies and databases tracking vaccination status of the deceased underscore the demand for greater transparency to disentangle the complex interplay between clinical interventions, vaccination effects, and excess mortality.

The persistence of elevated excess deaths following mass vaccination in 2021, which remained statistically uncorrelated with COVID injections but significantly linked to midazolam use, complicates the attribution of iatrogenic mortality between euthanasia protocols and vaccine effects. This 'iatrogenic pandemic' narrative echoes historical vaccination controversies from the 19th century, where flawed data and political agendas distorted public health responses. Despite modern technology, data collection accuracy in the UK has stagnated for over 150 years, as noted by parallels drawn to Alfred Russel Wallace's era, underscoring the enduring challenge of reliable mortality statistics in guiding ethical medical practice and policy.

By mid-2026, embalmers and funeral directors from Australia, New Zealand, and beyond reported an alarming rise in unusual white, rubbery blood clots found during post-mortem procedures, with some noting these clots in up to 30% of bodies and thrombosis-related deaths surging by as much as 600%. Major Tom Havilland’s survey of 269 embalmers revealed that 73% observed these clots in 2023 alone, describing them as long, sometimes 30 inches, and gradually forming before death. This emerging pathology appears to mimic common natural causes such as heart attacks and strokes, potentially obscuring its true impact on the documented excess mortality of approximately 100,000 deaths in the past year.

Despite the mounting physical evidence and growing concern from frontline embalmers and some medical practitioners, institutional responses have been marked by silence, suppression, and active obstruction. Reports indicate that coroners and hospitals have withheld autopsies and failed to follow up on these findings, with embalmers describing efforts to raise alarms as met with gaslighting and outright cover-ups, allegedly aligned with government policy. This institutional neglect extends to the medical community, where many doctors and pathologists remain unaware of the pathology, and public discourse is restricted, as Tonya, a co-host, lamented, 'We all know what it is... yet we are restricted from saying out loud what we truly believe it to be because we don't live in a free world anymore.'

Medical professionals have voiced urgent calls for transparency and independent investigation into these unusual clots and their possible links to excess mortality, emphasizing the need for comprehensive databases that correlate vaccination status with mortality outcomes. A U.S. physician highlighted the concerning rise in deaths correlated with 2021 and advocated for data-driven scrutiny to unravel this mystery. Meanwhile, international experts speculate that the pathology may stem from substances secreted by the vascular endothelium, suggesting a consistent and novel vascular condition that demands scientific attention beyond anecdotal reports.

The psychological toll on embalmers witnessing this phenomenon is profound, as many feel trapped by professional risks and institutional suppression. One embalmer described widespread distress, noting that colleagues fear speaking out due to threats of losing medical licenses or certifications, compounding the tragedy with a culture of silence. This climate of fear not only stifles critical discourse but also delays recognition and response to what may be a significant, yet unacknowledged, contributor to global excess mortality.

Early pandemic surveillance was marred by critical failures in data transparency and misclassification of deaths, severely hampering efforts to understand excess mortality. Calls for independent review bodies and comprehensive databases linking deaths to vaccination status highlight systemic gaps, exemplified by cases like a fully vaccinated 64-year-old man who died of a heart attack without an autopsy being performed. These shortcomings reflect a broader reluctance to investigate sudden deaths post-vaccination, underscoring the urgent need for transparent, accessible data to accurately capture COVID-19 and vaccine-related mortality.

Assumptions about asymptomatic spread and vaccine safety entrenched surveillance blind spots and constrained open scientific inquiry, complicating efforts to identify drivers of rising excess deaths. UK officials, including Chris Whitty, initially emphasized antibody testing to confirm asymptomatic transmission, yet when data failed to support this, public health narratives remained unchanged, leading to silence rather than correction. This reluctance to revise positions, despite sound antibody testing in the UK, reveals a bias that stifled transparent discussion and limited exploration of alternative explanations for mortality trends.

The early pandemic response was further compromised by a flawed understanding of the immune system and a human tendency to force explanations for untraceable infections, which fueled myths like widespread asymptomatic spread. As one analyst noted, authorities felt pressured to 'make something up' when infection sources were unknown, while oversimplified approaches risked unintended consequences by ignoring the immune system's complexity. This hubris, combined with inconsistent definitions of 'asymptomatic' between UK and Chinese medics, contributed to public health missteps and delayed acknowledgment of post-COVID syndromes and long-term sequelae that now appear to drive excess mortality.

By mid-2026, experts emphasized that without open data access and unbiased scientific discourse, the true causes behind the staggering 1,600 additional daily deaths worldwide remain elusive. Delayed diagnoses of severe conditions, including long COVID and its sequelae, highlight surveillance failures to capture the pandemic's full impact beyond acute infections. As one analyst urged, 'We must have more data and... discuss this data' openly to unravel the complex mortality patterns emerging post-pandemic and to inform effective healthcare responses.

The pandemic response profoundly challenged and, in many cases, eroded foundational Western ethical principles in public health policy, prompting urgent calls for their restoration. This ethical recalibration is essential not only to uphold scientific integrity but also to foster transparent inquiry, as exemplified by pathologist Dr. Clare Craig’s meticulous research into airborne virus transmission, which questioned prevailing assumptions about lockdowns, masks, and asymptomatic spread. Restoring these principles will enable a more nuanced and balanced approach to public health interventions that respects both individual rights and collective safety.

The polarizing nature of COVID-19 discourse, fueled by biased worst-case scenario modeling, entrenched fearful assumptions as unquestionable facts, effectively stifling dissenting scientific voices and undermining balanced policy-making. This dynamic, highlighted in analyses from mid-2026, underscores the critical need to reintroduce nuance and reality into pandemic debates to avoid repeating the pitfalls of overgeneralized interventions. By moving beyond alarmist projections and embracing evidence-based, transparent dialogue, public health policy can better weigh the complex trade-offs inherent in pandemic responses.